Tasisulam
Tasisulam Basic information
- Product Name:
- Tasisulam
- Synonyms:
-
- Benzamide, N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichloro-
- Ly573636
- Ly-573636
- TS81557
- LY573636 (TasisulaM)
- Tasisulam(Ly-573636
- N-(2,4-Dichlorobenzoyl)-5-bromothiophene-2-sulfonamide LY573636 Tasisulam
- Tasisulam N-(2,4-Dichlorobenzoyl)-5-bromothiophene-2-sulfonamide
- CAS:
- 519055-62-0
- MF:
- C11H6BrCl2NO3S2
- MW:
- 415.11
- Product Categories:
-
- Inhibitors
- Mol File:
- 519055-62-0.mol
Tasisulam Chemical Properties
- Density
- 1.812
- storage temp.
- Store at -20° C
- solubility
- DMF: 20 mg/ml; DMSO: 20 mg/ml; Ethanol: 10 mg/ml; PBS (pH 7.2): 0.2 mg/ml
- form
- A crystalline solid
- pka
- 3.45±0.10(Predicted)
- color
- Light yellow to yellow
Tasisulam Usage And Synthesis
Uses
The sodium salt of Tasisulam has potential antineoplastic activity. Selectively toxic towards tumor cells, tasisulam appears to induce tumor cell apoptosis by a mitochondrial-targeted mechanism involving the loss of mitochondrial membrane potential and induction of reactive oxygen species (ROS).
Biological Activity
Tasisulam (LY573636) is a SPLAM (SPLicing inhibitor sulfonAMide) th at bridges RNA binding motif protein 39 (RBM39; CAPERα, HCC1) and DCAF15 for interaction, thereby promoting (CUL4-DDB1-DDA1-DCAF15) E3 ubiquitin ligase complex-mediated RBM39 ubiquitination and subsequent proteasomal degradation. Tasisulam exerts selective toxicity in parental HCT116 cancer cultures (IC50 = 6.5 μM), but not those harboring non-CUL4-DCAF15-associating RBM39 G268V mutant even at a high concentration of 50 μM.
TasisulamSupplier
- Tel
- 021-61350663 13052117465
- sales@zehanbiopharma.com
- Tel
- sales@boylechem.com
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
- Tel
- +86057186818502 13588463833
- info@sagechem.com